Bridge Hospice 6390 Greenwich Drive, Suite 185, San Diego, CA, 92122 | |
(619) 453-5994 |
News Archive
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Recent public health efforts have focused extensively on reducing the amount of formula babies are given in the hospital after birth. But in the first randomized trial of its kind, researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life to infants experiencing high levels of early weight loss actually can increase the length of time their mothers end up breastfeeding.
The global epidemic of Type 2 diabetes is an indicator of serious underlying issues in our society, says a University of Sydney medical expert.
Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.
› Verified 6 days ago
Name | Bridge Hospice |
---|---|
Location | 6390 Greenwich Drive, Suite 185, San Diego, California |
Hospice ID | 751568 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 470 |
News Archive
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Recent public health efforts have focused extensively on reducing the amount of formula babies are given in the hospital after birth. But in the first randomized trial of its kind, researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life to infants experiencing high levels of early weight loss actually can increase the length of time their mothers end up breastfeeding.
The global epidemic of Type 2 diabetes is an indicator of serious underlying issues in our society, says a University of Sydney medical expert.
Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.
› Verified 6 days ago
NPI Number | 1700376951 |
Organization Name | Bridge Hospice East Bay Llc |
Address | 3021 Citrus Cir Ste 150 Walnut Creek, California, 94598 |
Phone Number | (619)453-5994 |
News Archive
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Recent public health efforts have focused extensively on reducing the amount of formula babies are given in the hospital after birth. But in the first randomized trial of its kind, researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life to infants experiencing high levels of early weight loss actually can increase the length of time their mothers end up breastfeeding.
The global epidemic of Type 2 diabetes is an indicator of serious underlying issues in our society, says a University of Sydney medical expert.
Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.
› Verified 6 days ago
NPI Number | 1710479233 |
Organization Name | Bridge Hospice Central Coast Llc |
Address | 601 E Romie Ln Ste 4 Salinas, California, 93901 |
Phone Number | (619)453-5994 |
News Archive
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Recent public health efforts have focused extensively on reducing the amount of formula babies are given in the hospital after birth. But in the first randomized trial of its kind, researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life to infants experiencing high levels of early weight loss actually can increase the length of time their mothers end up breastfeeding.
The global epidemic of Type 2 diabetes is an indicator of serious underlying issues in our society, says a University of Sydney medical expert.
Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.
› Verified 6 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 90.8 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 76.9 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 78.5 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 48.3 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 86.2 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Recent public health efforts have focused extensively on reducing the amount of formula babies are given in the hospital after birth. But in the first randomized trial of its kind, researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life to infants experiencing high levels of early weight loss actually can increase the length of time their mothers end up breastfeeding.
The global epidemic of Type 2 diabetes is an indicator of serious underlying issues in our society, says a University of Sydney medical expert.
Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.
› Verified 6 days ago
Home Health Aides | 3 |
Homemakers | 1 |
Licensed Practical or Vocational Nurses | 4 |
Medical Social Workers | 1.5 |
Physicians | 1.5 |
Registered Nurses | 6 |
Other Personnel | 5 |
Total Employees | 22 |
---|
News Archive
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Recent public health efforts have focused extensively on reducing the amount of formula babies are given in the hospital after birth. But in the first randomized trial of its kind, researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life to infants experiencing high levels of early weight loss actually can increase the length of time their mothers end up breastfeeding.
The global epidemic of Type 2 diabetes is an indicator of serious underlying issues in our society, says a University of Sydney medical expert.
Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.
› Verified 6 days ago
Others | 2 |
Total Volunteers | 2 |
---|
News Archive
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Recent public health efforts have focused extensively on reducing the amount of formula babies are given in the hospital after birth. But in the first randomized trial of its kind, researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life to infants experiencing high levels of early weight loss actually can increase the length of time their mothers end up breastfeeding.
The global epidemic of Type 2 diabetes is an indicator of serious underlying issues in our society, says a University of Sydney medical expert.
Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.
› Verified 6 days ago
Scripps Hospice Location: 4311 Third Avenue, Suite C, San Diego, California, 92103 Phone: (619) 453-5994 |
Kaiser Foundation Hospital San Diego Hospice Location: 10992 San Diego Mission Road Building 2 Suite 3401, San Diego, California, 92108 Phone: (619) 453-5994 |
Vitas Healthcare Corporation Of California Location: 9655 Granite Ridge Drive, Suite 300, San Diego, California, 92123 Phone: (619) 453-5994 |
Gentiva Hospice Location: 9444 Balboa Avenue Suite 290, San Diego, California, 92123 Phone: (619) 453-5994 |